FI102756B1 - Förfarande för framställning av terapeutiskt användbara 6H-bensfuro[3a,3,3-ef][2]bensazepinderivat - Google Patents

Förfarande för framställning av terapeutiskt användbara 6H-bensfuro[3a,3,3-ef][2]bensazepinderivat

Info

Publication number
FI102756B1
FI102756B1 FI895213A FI895213A FI102756B1 FI 102756 B1 FI102756 B1 FI 102756B1 FI 895213 A FI895213 A FI 895213A FI 895213 A FI895213 A FI 895213A FI 102756 B1 FI102756 B1 FI 102756B1
Authority
FI
Finland
Prior art keywords
benzofuro
benzazepine derivatives
therapeutically utilizable
preparing therapeutically
preparing
Prior art date
Application number
FI895213A
Other languages
English (en)
Finnish (fi)
Other versions
FI895213A0 (fi
FI102756B (sv
Inventor
Bonnie Davis
Madeleine Joullie
Original Assignee
Bonnie Davis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bonnie Davis filed Critical Bonnie Davis
Publication of FI895213A0 publication Critical patent/FI895213A0/fi
Application granted granted Critical
Publication of FI102756B1 publication Critical patent/FI102756B1/sv
Publication of FI102756B publication Critical patent/FI102756B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Eye Examination Apparatus (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Processing Of Meat And Fish (AREA)
  • Compression Or Coding Systems Of Tv Signals (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI895213A 1987-05-04 1989-11-02 Förfarande för framställning av terapeutiskt användbara 6H-bensfuro£3a ,3,3-ef|£2|bensazepinderivat FI102756B (sv)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US4652287A 1987-05-04 1987-05-04
US4652287 1987-05-04
US8801542 1988-05-04
PCT/US1988/001542 WO1988008708A1 (en) 1987-05-04 1988-05-04 Compounds for the treatment of alzheimer's disease
CA569641 1988-06-16
CA000569641A CA1338326C (en) 1987-05-04 1988-06-16 Compounds for the treatment of alzheimer's disease

Publications (3)

Publication Number Publication Date
FI895213A0 FI895213A0 (fi) 1989-11-02
FI102756B1 true FI102756B1 (sv) 1999-02-15
FI102756B FI102756B (sv) 1999-02-15

Family

ID=42046403

Family Applications (1)

Application Number Title Priority Date Filing Date
FI895213A FI102756B (sv) 1987-05-04 1989-11-02 Förfarande för framställning av terapeutiskt användbara 6H-bensfuro£3a ,3,3-ef|£2|bensazepinderivat

Country Status (10)

Country Link
EP (1) EP0363415B1 (sv)
JP (1) JP2755403B2 (sv)
KR (1) KR100195399B1 (sv)
AT (1) ATE411026T1 (sv)
AU (1) AU632458B2 (sv)
CA (1) CA1338326C (sv)
DE (1) DE3856594D1 (sv)
DK (1) DK175839B1 (sv)
FI (1) FI102756B (sv)
WO (1) WO1988008708A1 (sv)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ242744A (en) * 1991-05-14 1997-02-24 Ernir Snorrason Use of a cholinesterase inhibitor (eg a galanthamine derivative) for treating fatigue
US5336675A (en) * 1991-05-14 1994-08-09 Ernir Snorrason Method of treating mania in humans
US5153193A (en) * 1991-10-01 1992-10-06 Hoechst-Roussel Pharmaceuticals Incorporated Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs
US6323195B1 (en) * 1993-10-15 2001-11-27 Aventis Pharmaceuticals Inc. Galanthamine derivatives as acetylcholinesterase inhibitors
US6323196B1 (en) * 1993-10-15 2001-11-27 Aventis Pharmaceuticals Inc. Galanthamine derivatives as acetylcholinesterase inhibitors
US6316439B1 (en) * 1993-10-15 2001-11-13 Aventis Pharamaceuticals Inc. Galanthamine derivatives as acetylcholinesterase inhibitors
AT401058B (de) * 1994-10-21 1996-06-25 Waldheim Pharmazeutika Gmbh Verfahren zum herstellen von derivaten des 4a,5, 9,10,11,12,-hexahydro-6h-benzofuro(3a,-3,2-ef) (2)benzazepins
US6407229B1 (en) 1994-10-21 2002-06-18 Sanochemia Pharmazeutika Ag Processes for the preparation of derivatives of 4a,5,9,10,11,12-hexahydro-6H-benzofuro-[3a,3,2-ef][2] benzazapine
CA2203183C (en) * 1994-10-21 2008-04-08 Laszlo Czollner Process for producing derivatives of 4a,5,9,10,11,12,-hexahydro-6h-benzofuro[3a,3,2-ef][2]benzazepine
GB9506843D0 (en) 1995-04-03 1995-05-24 Chiroscience Ltd Oxidative process and products thereof
GB9514821D0 (en) * 1995-07-19 1995-09-20 Sod Conseils Rech Applic Galanthamine derivatives
GB9519267D0 (en) * 1995-09-21 1995-11-22 Chiroscience Ltd Preparation of alkaloids
AT403803B (de) 1996-04-19 1998-05-25 Sanochemia Ltd Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
US7939522B1 (en) 1998-11-23 2011-05-10 Bonnie M Davis Dosage formulations for acetylcholinesterase inhibitors
AU2004242546B2 (en) * 1998-11-23 2008-05-15 Bonnie Davis Dosage formulations for acetylcholinesterase inhibitors
OA11740A (en) 1998-12-24 2005-05-13 Janssen Pharmaceutica Nv Controlled release galantamine composition.
WO2001043697A2 (en) 1999-12-10 2001-06-21 Bonnie Davis Analogs of galanthamine and lycoramine as modulators of nicotinic receptors
AU785385B2 (en) 2000-03-31 2007-03-29 Sanochemia Pharmazeutika Aktiengesellschaft Novel derivatives and analogues of galanthamin
US20030162770A1 (en) 2002-02-22 2003-08-28 Davis Bonnie M. Use of modulators of nicotinic receptors for treatment of cognitive dysfunction
US20090253654A1 (en) 2005-09-22 2009-10-08 Galantos Pharma Gmbh Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment
JP2009508903A (ja) * 2005-09-22 2009-03-05 ガラントス ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング 認知障害を伴う疾患の治療に用いるための脳血液関門透過性が改善されたコリン作用増強剤
EP1777222A1 (en) * 2005-09-22 2007-04-25 Galantos Pharma GmbH Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment
EP2137192B8 (en) 2008-04-14 2014-06-11 Neurodyn Life Sciences Inc. Derivatives of galantamine as pro-drugs for the treatment of human brain diseases
US9625475B2 (en) 2008-09-29 2017-04-18 Abbvie Inc. Indole and indoline derivatives and methods of use thereof
TW201018694A (en) 2008-09-29 2010-05-16 Abbott Lab Indole and indoline derivatives and methods of use thereof
WO2011100373A1 (en) 2010-02-09 2011-08-18 The Johns Hopkins University Methods and compositions for improving cognitive function
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia
MX362886B (es) 2012-12-13 2019-02-22 H Lundbeck As Composición sinérgica que comprende vortioxetina y donepezilo para incrementar los niveles de acetilcolina en el cerebro, y el uso de la misma en el tratamiento de una disfunción cognitiva.
EP3827820A1 (en) 2013-03-15 2021-06-02 The Johns Hopkins University Brivaracetam for improving cognitive function
JP6433482B2 (ja) 2013-03-15 2018-12-05 エージンバイオ， インコーポレイテッド 認知機能を改善するための方法および組成物
WO2016191288A1 (en) 2015-05-22 2016-12-01 Agenebio, Inc. Extended release pharmaceutical compositions of levetiracetam

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3673177A (en) * 1970-05-04 1972-06-27 American Cyanamid Co Substituted 4-(anilinomethylene)-3-galanthamaninones
PL122665B1 (en) * 1978-11-21 1982-08-31 Edinen Zentar Chim Process for preparing novel dienones of narvedine type and their derivatives
US4663318A (en) * 1986-01-15 1987-05-05 Bonnie Davis Method of treating Alzheimer's disease
NL8800350A (nl) * 1988-02-12 1989-09-01 Stichting Biomedical Research Synthetische galanthamine-derivaten, werkwijze voor het bereiden daarvan, en farmaceutische samenstellingen.

Also Published As

Publication number Publication date
JPH02503794A (ja) 1990-11-08
KR890701107A (ko) 1989-12-19
WO1988008708A1 (en) 1988-11-17
FI895213A0 (fi) 1989-11-02
ATE411026T1 (de) 2008-10-15
EP0363415B1 (en) 2008-10-15
AU632458B2 (en) 1993-01-07
KR100195399B1 (ko) 1999-06-15
EP0363415A1 (en) 1990-04-18
DK175839B1 (da) 2005-03-21
DK549189D0 (da) 1989-11-03
CA1338326C (en) 1996-05-14
DK549189A (da) 1990-01-03
JP2755403B2 (ja) 1998-05-20
AU1808488A (en) 1988-12-06
FI102756B (sv) 1999-02-15
EP0363415A4 (en) 1993-03-17
DE3856594D1 (de) 2008-11-27

Similar Documents

Publication Publication Date Title
FI102756B1 (sv) Förfarande för framställning av terapeutiskt användbara 6H-bensfuro[3a,3,3-ef][2]bensazepinderivat
GR3004925T3 (sv)
FI93117C (sv) Analogiförfarande för framställning av terapeutiskt användbara 9-aminotetrahydroakridinderivat
GR3005470T3 (sv)
HUT68166A (en) Process for preparing substituted piperidines
ZA863382B (en) Quinolylglycinamide derivatives,the process for preparation thereof and their therapeutic application as psychotropic drugs
HU901428D0 (en) Process for the preparation of 5-substituted 1,4-dihydro-4-oxo-naphthiridine-3-carboxylic acid derivatives
GR3017384T3 (en) Process for the preparation of 2,7-Diazabicyclo(3.3.O)octanes.
HUT47430A (en) Process for producing pharmaceutical compositions containing 2-pyrimidinyl-1-piperazine derivatives for treating alcoholizmus
HU908437D0 (en) Process for the production of 10-(2'-hydroxy-3'-alcoxy-1,4,7-tris-carboxymethyl-1,4,7,10-tetraazacyclododecanes
HU908436D0 (en) Process for the production of 10-(2'-hydroxy-3"-polyoxaalkyl/1,4,7-tris-carboxymethyl-1,4,7,10-tetraazacyclododecanes
GR3001310T3 (en) Hydroxypyrazole derivatives, process for their preparation and their use against microbes
EP0297496A3 (en) Novel process for the preparation of 6,7-diacyl-7-deacetylforskolin derivatives
DE3463143D1 (en) 1-0-alkyl-3-amino-propan-1.2-diol-2-0-phospholipids, process for producing the same and pharmaceutical preparations containing the same
PT86623A (pt) Process for the preparation of derivatives of 3-aryl-5-alkylthio-4h-1,2,4-triazoles
GR3002884T3 (en) Substituted chinoxalyl-imidazolidine-2,4-diones, process for their preparation, their use as medicaments and pharmacological preparations
ZA88639B (en) Substituted 3-phenyl-7h-thiazolo(3,2-b)(1,2,4)triazin-7-ones,a process for the preparation thereof,medicaments containing same and the use thereof,and also some intermediates formed in the preparation of the compounds mentioned
ZA903944B (en) Pyrrolidone derivatives the process for their preparation and the pharmaceutical compositions containing them
EP0365913A3 (en) Substituted 2-aminothiazoles
HU905030D0 (en) Process for producing new 1,3-oxazines and pharmaceutical preparatives containing these compounds
HUT46321A (en) Process for producing pyrethrinoid derivatives
FI92393B (sv) Förfarande för framställning av 1,5-bensotiazepinderivat
EP0445643A3 (en) Process for preparation of 3,3-dialkyl-1-methyl-2-methyleneindolines
DE3469358D1 (en) Novel 3-(4'-aminobutylamino)-propylamino-bleomycin derivatives, a process for their preparation and their use as medicaments
YU116389A (en) Process for preparing derivatives of 1,3-diazolyl-2-propanole

Legal Events

Date Code Title Description
FG Patent granted

Owner name: DAVIS, BONNIE

MA Patent expired